TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
IMMX

Immix Biopharma Inc

Healthcare · Biotechnology

11.00$ -6.2% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Immix Biopharma Inc (IMMX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 239 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet IMMX
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
22 20 34 29 25 23 20 16 20 105 96 239
22 20 33 27 23 20 17 12 17 101 92 234
20 18 29 24 20 18 16 12 16 94 79 225
20 18 29 24 20 18 16 12 16 100 91 232
0.7 1.2 2.0 2.0 2.0 2.0 – – – – – –
– – 0.0 – – – – – – – – –
2.8 3.7 6.7 4.9 7.6 9.7 10 11 12 11 11 10
2.8 3.7 5.7 3.9 6.6 8.7 9.3 10 11 10 11 9.3
– – 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1
1.6 1.4 3.5 2.3 3.3 5.4 5.7 6.6 7.1 5.4 4.7 5.3
20 16 28 24 18 13 9.6 4.7 8.3 94 84 229
-48 -53 -59 -63 -70 -75 -80 -86 -94 -104 -115 -126
19 20 23 29 29 28 30 30 32 38 55 64

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?